Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21672123 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
Condition: Type 2 Diabetes
Interventions: Drug: dapagliflozin;   Drug: Glimepiride;   Drug: metformin hydrochloride;   Drug: pioglitazone hydrochloride;   Drug: Rosiglitazone

Indicates status has not been verified in more than two years